Shipped from our

warehouses across the US

The Next Generation of Gut Health

Europe's leading next-generation probiotic with 53 diverse strains for true microbiome diversity. Now available in the US.

10 million customers worldwide | Over 20,000 positive reviews

1

#

Digestive health probiotic strain in Europe

Contains the

GMP

C

E

R

T

I

F

I

E

D

C

E

R

T

I

F

I

E

D

30

DAYS

G

U

A

R

A

N

T

E

E

M

O

N

E

Y

 

B

A

C

K

  • “...I was impressed by the uncompromising focus on microbiome research.” - Martin G.

  • “...I was impressed by the uncompromising focus on microbiome research.” - Martin G.

  • “...I was impressed by the uncompromising focus on microbiome research.” - Martin G.

Tried a Probiotic but Still Dealing with Gut Issues?

Here’s how we’re different…

You’re not alone. Many generic probiotics contain only a handful of bacterial strains – 5, 10, maybe 20. But your gut microbiome is an ecosystem of over 100 different bacterial species working together, similar to a garden or rainforest. Taking a supplement with just a few strains is like trying to replant a rainforest with a few seeds from the same tree – it simply can’t restore what’s missing.

Going Beyond Digestive Health

The best of probiotic science, brought together in one capsule

Gut barrier function*

Intestinal regularity*

Healthy skin*

Nervous system function*

Nervous system function*

Gastrointestinal health

What makes Kijimea K53 different?

53 of Strains

24 strains

Manufacturer’s own clinical studies

Manufacturer’s own clinical studies

Manufacturer’s own clinical studies

With Vitamin B₆

No Vitamin B₆

Moisture-proof alu-alu packaging

No moisture-proof packaging

Why Is Kijimea K53 a Major Breakthrough?

Why Is Kijimea K53 a Major Breakthrough?

Kijimea K53 is formulated to support the diversity of the gut microbiome with a unique and comprehensive blend of 53 diverse strains. Going beyond digestive health, Kijimea K53 supports immune system function, healthy skin, nervous system function, and healthy protein metabolism — because your gut is connected to so much more than digestion.

B. lactis BB-12 — for a healthy microbiome

L. rhamnosus GG — the world’s most extensively studied probiotic strain

L. rhamnosus IMC 501 & L. paracasei IMC 502 — for regularity

Zinc & Vitamin B₆ — beyond the gut

B. bifidum MIMBb75 — for gastrointestinal comfort

L. rhamnosus GG — the world’s most extensively studied probiotic strain

L. rhamnosus IMC 501 & L. paracasei IMC 502 — for regularity

L. rhamnosus GG — for gut barrier function & occasional diarrhea

A Brand You Can Trust

10+ million customers worldwide, Bestseller in Europe, Manufactured in Germany to strict standards,
30-day money-back guarantee

30

DAYS

G

U

A

R

A

N

T

E

E

M

O

N

E

Y

 

B

A

C

K

GMP

C

E

R

T

I

F

I

E

D

C

E

R

T

I

F

I

E

D

L

A

B

O

R

A

T

O

R

Y

T

E

S

T

E

D

30-day money-back guarantee. Free shipping on subscriptions.

Julie-Ann Wilkinson

Verified Buyer

No side effects.

"No side effects.
Excellent packaging.
Capsules are small and easy to swallow."

Nicky Windle 

Verified Buyer

Effective...

"Effective and packed full of goodness to support the gut"

Maria Hacker

Verified Buyer

I am very satisfied with the product.

"I am very satisfied with the product. The capsules are small and easy to swallow. The newsletter that comes with it is a great addition and very helpful."

4,6

4,7

Fantastic

Angela F.

“They are very good for me! I think it's excellent that all the tablets are packed airtight!”

The reviews and user experiences presented on this website are based on voluntary feedback from real customers. They reflect individual experiences and may not be representative of typical results.

30-day money-back guarantee. Free shipping on subscriptions.

Questions?

We are happy to help

What can I expect while taking Kijimea PRO?

Kijimea PRO is a probiotic supplement specifically formulated to support the gut barrier function and gastrointestinal comfort*. It combines 4 clinically validated strains, incl. patented B. bifidum MIMBb75.

How do I take Kijimea PRO?

Take one capsule daily with sufficient amount of water. Daily use for at least 12 weeks is recommended.

Do not exceed recommended daily dose. Keep out of reach of children.

Why should I take Kijimea PRO daily?

Consistent use can help to support the benefits of the clinically studied strains*.
We recommend a daily use for at least 12 weeks. When starting, the gut microbiome may take some time to adjust to the daily introduction of probiotics.

Do I need to refrigerate Kijimea PRO?

No refrigeration is necessary.

Is Kijimea PRO safe to take while I'm pregnant or breastfeeding?

As with any dietary supplement or new health protocol, we recommend consulting a healthcare professional before you start consuming Kijimea PRO if you are pregnant or breastfeeding or trying to become pregnant.

What pack sizes of Kijimea PRO are available?

Kijimea PRO is available in the following pack size:

30 capsules of 0.28 g each = 8.4 g.

Is Kijimea PRO suitable for children?

There are no known side effects and interactions associated with the consumption of Kijimea PRO. Consult your healthcare professional if you are taking, have recently taken or are planning to take any medicines together with Kijimea PRO.

This product contains no allergens according to Food Allergen Labeling and Consumer Protection Act (FALCPA).

Is Kijimea PRO well tolerated?

There are no known side effects and interactions associated with the consumption of Kijimea PRO. Consult your healthcare professional if you are taking, have recently taken or are planning to take any medicines together with Kijimea PRO.

This product contains no allergens according to Food Allergen Labeling and Consumer Protection Act (FALCPA).

Who is the distributor of Kijimea PRO?

The product is distributed by Kijimea Inc. (120 Wall Street, New York, NY 10005)

30-day money-back guarantee. Free shipping on subscriptions.

Don’t Miss Out on
This Special Offer

Don’t Miss Out on
This Special Offer

Subscribe & Save

One-Time purchase

Subscribe & Save

Delivered monthly.

Pause or cancel anytime.

Free shipping on subscriptions.

40% off on first order.

$49 billed monthly from 2nd order.

1-month supply

$59

$35

Delivered monthly

We recommend 3–6 months of consistent use to see results.

Order now, pay later with:

Our mission

Make probiotics the foundation of a longer and healthier life – for all.

100% Satisfaction on all our products

We want you to be 100% satisfied with your Kijimea products. That’s why every order comes with a 30-day money-back guarantee.

References

References

1. Ma S. K., Zhang S. et al. Evaluation of probiotic strains and their effects on digestive health, gut microbiota, and gastrointestinal comfort.

Agamennone, V., Krul, C. A. M., Rijkers, G., & Kort, R. (2018). A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC gastroenterology18(1), 103. https://doi.org/10.1186/s12876-018-0831-x. PMID: 30078376; PMCID: PMC6091175.

Dronkers TMG, Ouwehand AC, Rijkers GT. Global analysis of clinical trials with probiotics. Heliyon. 2020 Jul 7;6(7):e04467. doi: 10.1016/.heliyon.2020.e04467. PMID: 32715136; PMCID: PMC7371762.

Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B, Eskesen D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorganisms. 2014 Mar 28;2(2):92-110. doi:10.3390/microorganisms2020092. PMID: 27682233; PMCID: PMC5029483.

Li, Y. T., Xu, H., Ye, J. Z., Wu, W. R., Shi, D., Fang, D. Q., Liu, Y., & Li, L. J. (2019). Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis. World journal of gastroenterology25(33), 4999–5016.
https://doi.org/10.3748/wjg.v25.i33.4999. PMID: 31543689; PMCID: PMC6737314.

McFarland L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. The American journal of gastroenterology, 101(4), 812-822. https://doi.org/10.1111/j.1572-0241.2006.00465.x
PMID: 16635227.

Merenstein D, Fraser CM, Roberts RF, Liu T, Grant-Beurmann S, Tan TP, Smith KH, Cronin T, Martin OA, Sanders ME, Lucan SC, Kane MA. Bifidobacterium animalis subsp. lactis BB-12
Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome. Nutrients. 2021 Aug 17;13(8):2814. doi: 10.3390/nu13082814. PMID: 34444974; PMCID: PMC8398419.

Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S., & Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet. Infectious diseases6(6), 374–382. https://doi.org/10.1016/S1473-3099(06)70495-9. PMID: 16728323.

Silvi S, Verdenelli MC, Cecchini C, Coman MM, Bernabei MS, Rosati J, De Leone R,
Orpianesi C, Cresci A. Probiotic-enriched foods and dietary supplement containing SYNBIO positively affects bowel habits in healthy adults: an assessment using standard statistical analysis and Support Vector Machines. Int J Food Sci Nutr. 2014 Dec;65(8):994-1002. doi: 10.3109/09637486.2014.940284. Epub 2014 Jul 21. PMID: 25045832.

Szajewska, H., Canani, R. B., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., van Goudoever, J. B., Weizman, Z., & ESPGHAN Working Group for ProbioticsPrebiotics (2016). Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. Journal of pediatric gastroenterology and nutrition62(3), 495–506. https://doi.org/10.1097/MPG.0000000000001081.
PMID: 25756877.


Szajewska, H., & Kołodziej, M. (2015). Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary pharmacology & therapeutics42(10), 1149–1157. https://doi.org/10.1111/apt.13404. PMID:26365389.


Szajewska, H., Konarska, Z., & Kołodziej, M. (2016). Probiotic Bacterial and Fungal Strains: Claims with Evidence. Digestive diseases (Basel, Switzerland)34(3), 251–259. https://doi.org/10.1159/000443359.
PMID:27028756.


Szajewska, H., Skórka, A., Ruszczyński, M., & Gieruszczak-Białek, D. (2013). Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children--updated analysis of randomised controlled trials. Alimentary pharmacology & therapeutics38(5), 467–476. https://doi.org/10.1111/apt.12403. PMID: 23841880.

Vandenplas, Y., Huys, G., & Daube, G. (2015). Probiotics: an update. Jornal de pediatria91(1), 6–21. https://doi.org/10.1016/j.jped.2014.08.005.
PMID: 25458874.

Vizioli C, Jaime-Lara R, Daniel SG, Franks A, Diallo AF, Bittinger K, Tan TP, Merenstein DJ, Brooks B, Joseph PV, Maki KA. Administration of Bifidobacterium animalis subsp. lactis Strain BB-12 ® in
Healthy Children: Characterization, Functional Composition, and Metabolism of the Gut Microbiome. medRxiv [Preprint]. 2023 Feb 6:2023.02.02.23285145. doi: 10.1101/2023.02.02.23285145. Update in: Front Microbiol. 2023 May 12;14:1165771. doi: 10.3389/fmicb.2023.1165771. PMID: 36798243; PMCID: PMC9934720.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

*Customer survey on the product K53 (Europe), conducted between October 31, 2025 and December 12, 2025 in Europe. Self-assessment by 522 customers regarding recommendation, satisfaction, tolerability, expectations, and repurchase intentions. Participation was voluntary, anonymous, and without financial incentives.

*Customer survey on the product K53 (Europe), conducted between October 31, 2025 and December 12, 2025 in Europe. Self-assessment by 522 customers regarding recommendation, satisfaction, tolerability, expectations, and repurchase intentions. Participation was voluntary, anonymous, and without financial incentives.

2. Dimidi E., Christodoulides S., Fragkos K. C., Scott S. M., Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis.

3. Williams E. A., Stimpson J., Wang D., Plummer S., Garaiova I., Barker M. E., Corfe B. M. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome.

4. Ford A. C., Quigley E. M. M., Lacy B. E., Lembo A. J., Saito Y. A., Schiller L. R., Soffer E. E., Spiegel B. M. R., Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation.

5. McFarland L. V. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review.

6. Hill C., Guarner F., Reid G., Gibson G. R., Merenstein D. J., Pot B., Morelli L., Canani R. B., Flint H. J., Salminen S., Calder P. C., Sanders M. E. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

7. You can find the complete list of scientific references and supporting study information on the original Kijimea K53 product offer page.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Individual results may vary. Please consult your physician before use if you are pregnant, nursing, taking medication, or have a medical condition.

Terms & conditions

Privacy policy

Accessibility

Return Policy

Do not Sell or Share my personal information

© 2026, Kijimea Inc.